Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 plus Leucovorin (1-week on/1-week off) in metastatic colorectal cancer
NCT00891332Phase 2Completed
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Oct 2008
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of tegafur in metastatic colorectal cancer (mCRC), sponsored by Taiho Pharmaceutical Co., Ltd.. Started Oct 2008; status: completed.
02
Drugs
tegafur
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00891332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00891332.